Article
Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity
8 Jun 2021
Abstract excerpt
Alpha Thalassemia/Mental Retardation Syndrome X-Linked (ATRX) is mutated frequently in gliomas and represents a potential target for cancer therapies. ATRX is known to function as a histone chaperone that helps incorporate histone variant, H3.3, into the genome. Studies have implicated ATRX in key DNA damage response (DDR) pathways but a distinct role in DNA repair has yet to be fully elucidated. To further...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
